News

CHICAGO – Although the drug epinephrine (adrenaline) is widely used in cardiopulmonary resuscitation for out-of-hospital cardiac arrest, an analysis that included more than 400,000 patients finds that receipt of the drug for this use was...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that that it will display the LifeVest® Wearable Defibrillator, the AutoPulse® Non-invasive Cardiac Support Pump, the R Series® Code-Ready®...

Thermedical, a privately held company developing proprietary thermal therapy equipment for numerous clinical conditions, announced that it closed $1.5 million in Series A funding with a private investor, Samuel H. Maslak, Sc.D. The financing...

Abiomed Inc., a leading provider of breakthrough heart support technologies, announced its schedule of events at the American College of Cardiology (ACC) 2012 Scientific Sessions in Chicago, IL. At ACC 2012, there will be six Impella poster...

Gencaro Potentially the First Genetically-Targeted Treatment for Prevention of Atrial Fibrillation ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular...

The Canadian Journal of Cardiology has published a focused update to the Canadian Cardiovascular Society's atrial fibrillation guidelines. Atrial fibrillation is the most common cardiac arrhythmia and is a significant cause of stroke,...

Biomedical Systems, a global provider of cardiac diagnostic services and products, has introduced the TruVue® Wireless Ambulatory ECG Monitoring System for the diagnosis and management of atrial fibrillation and other complex cardiac...

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, announced that a new study published online in the Heart Rhythm Journal confirms the value of Microvolt T-Wave Alternans™ (MTWA) testing for identifying...

Cardiome Pharma Corp. announced that Merck, known as MSD outside the United States and Canada, has communicated to Cardiome their decision to discontinue further development of the oral formulation of vernakalant. The decision was based on...

World’s Only Completely Subcutaneous Implantable Defibrillator is an Important New Alternative for Patients at Risk of Sudden Cardiac Arrest Cameron Health, Inc. announced that the U.S. Food and Drug Administration (FDA) Circulatory System...